Long-term thromboxane-synthase inhibition prolongs survival in murine lupus nephritis
- 1 April 1995
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 47 (4) , 1168-1175
- https://doi.org/10.1038/ki.1995.166
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Thromboxane and prostacyclin differentially regulate murine extracellular matrix gene expressionKidney International, 1993
- N-imidazolyl derivatives of the napththalene and chroman rings as thromboxane A2 synthase inhibitorsEuropean Journal of Medicinal Chemistry, 1991
- Enhanced renal leukotriene production in murine lupus: Role of lipoxygenase metabolitesKidney International, 1991
- Improvement of Renal Function with Selective Thromboxane Antagonism in Lupus NephritisNew England Journal of Medicine, 1989
- Effect of Eicosapentaenoic Acid Rich Menhaden Oil and MaxEPA on the Autoimmune Disease of Mrl/l MiceInternational Archives of Allergy and Immunology, 1989
- Therapy of Lupus NephritisNew England Journal of Medicine, 1986
- Increased renal thromboxane production in murine lupus nephritis.Journal of Clinical Investigation, 1986
- Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.Circulation, 1983
- Estimating survival functions from the life tableJournal of Chronic Diseases, 1969
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958